ALK gets German approval extended: “An important part of our strategy for the future”
Allergy business ALK expects to strengthen its position in the German market after the company received the green light from the country’s authorities to reduce the necessary number of inejctions per treatment round by more than half.
BY ALBERT RØNNING-ANDERSSON
Seven injections instead of up to sixteen. It will now become more comfortable and convenient for German allergy sufferers to be vaccinated against dust, grass and pollen allergies.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
